December 2024's Leading Growth Companies With Insider Stakes

In This Article:

As global markets navigate a mixed economic landscape, with U.S. consumer confidence dipping and major stock indexes experiencing fluctuations, investors are increasingly focusing on growth opportunities that demonstrate resilience and potential. In this context, companies with high insider ownership often attract attention due to the alignment of interests between management and shareholders, suggesting a commitment to long-term success amidst the current market volatility.

Top 10 Growth Companies With High Insider Ownership

Name

Insider Ownership

Earnings Growth

Archean Chemical Industries (NSEI:ACI)

22.9%

41.3%

SKS Technologies Group (ASX:SKS)

29.7%

24.8%

Kirloskar Pneumatic (BSE:505283)

30.3%

26.3%

Propel Holdings (TSX:PRL)

23.8%

37.6%

On Holding (NYSE:ONON)

19.1%

29.4%

Plenti Group (ASX:PLT)

12.8%

120.1%

Brightstar Resources (ASX:BTR)

16.2%

84.5%

Fine M-TecLTD (KOSDAQ:A441270)

17.2%

131.1%

Credo Technology Group Holding (NasdaqGS:CRDO)

13.3%

66.3%

Fulin Precision (SZSE:300432)

13.6%

66.7%

Click here to see the full list of 1507 stocks from our Fast Growing Companies With High Insider Ownership screener.

We're going to check out a few of the best picks from our screener tool.

CanSino Biologics

Simply Wall St Growth Rating: ★★★★★☆

Overview: CanSino Biologics Inc. is a company that develops, manufactures, and commercializes vaccines in the People's Republic of China with a market cap of HK$11.29 billion.

Operations: The company's revenue segment includes CN¥748.53 million from the research and development of vaccine products for human use.

Insider Ownership: 28.5%

Earnings Growth Forecast: 141.4% p.a.

CanSino Biologics demonstrates strong growth potential with insider ownership, as insiders have shown confidence by buying more shares over the past three months. The company is trading significantly below its estimated fair value and is expected to achieve substantial revenue growth of 33.3% annually, outpacing the Hong Kong market. Recent product developments, including vaccines for polio and diphtheria-tetanus-pertussis, highlight its innovative pipeline. Despite a current net loss, profitability is anticipated within three years.

SEHK:6185 Ownership Breakdown as at Dec 2024
SEHK:6185 Ownership Breakdown as at Dec 2024

Ming Yang Smart Energy Group

Simply Wall St Growth Rating: ★★★★★☆

Overview: Ming Yang Smart Energy Group Limited is involved in the R&D, design, manufacture, sale, maintenance, and operation of energy equipment and wind turbines in China with a market cap of CN¥27.63 billion.